Bioera S.p.A. (BIE.MI)

EUR 0.04

(0.0%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 1.49 Million 128 Thousand 969 Thousand 10.33 Million 30.22 Million 39.21 Million
Cost of Revenue 668 Thousand 1.04 Million 2.26 Million 11.88 Million 29.48 Million 37.26 Million
Gross Profit 824 Thousand -919 Thousand -1.29 Million -1.54 Million 740 Thousand 1.94 Million
Operating Expenses 4.19 Million 2.29 Million 1.46 Million 4.43 Million 5.66 Million 3.82 Million
Selling, General and Administrative Expenses 457 Thousand 1.16 Million 1.97 Million 4.94 Million 8.75 Million 11.1 Million
Research and Development Expenses - - - - - -
Other Expenses 3.73 Million 2.29 Million 1.46 Million 4.43 Million 5.66 Million 3.82 Million
Cost and Expenses 4.86 Million 3.33 Million 3.72 Million 16.31 Million 35.15 Million 41.08 Million
Operating Income -3.36 Million -3.6 Million 15.89 Million -6.06 Million -4.92 Million -1.87 Million
Interest Expense 270 Thousand 135 Thousand 344 Thousand 663 Thousand 487 Thousand 438 Thousand
Income Tax Expense 2000.00 22 Thousand -21.38 Million 214 Thousand 396 Thousand 684 Thousand
Earnings before Tax -3.59 Million -4.09 Million 15.34 Million -7.13 Million -7.52 Million -3.39 Million
Net Income -3.13 Million -4.11 Million 36.73 Million -7.34 Million -7.92 Million -4.08 Million
Earnings Per Share Basic -0.15 -0.96 12.81 -6.13 -10.85 -5.84
Earnings Per Share Diluted -0.15 -0.96 12.81 -6.13 -10.85 -5.84
Weighted Average Shares Outstanding 20.57 Million 4.28 Million 2.86 Million 1.19 Million 730.18 Thousand 699.09 Thousand
Weighted Average Shares Outstanding (Diluted) 20.57 Million 4.28 Million 2.86 Million 1.19 Million 730.18 Thousand 699.09 Thousand
Gross Margin 0.55 -7.18 -1.33 -0.15 0.02 0.05
EBIT Margin -2.14 -27.56 -2.82 -0.53 -0.17 -0.04
Profit Margin -2.10 -32.13 37.91 -0.71 -0.26 -0.10
EBITDA -3.19 Million -4.59 Million 16.09 Million -4.72 Million -4.1 Million -2.3 Million
Earnings Before Tax Margin -2.26 -28.16 16.40 -0.59 -0.16 -0.05

Income Statement Charts